Dr. Daniel W Wright, DO Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 204 N 4th Ave E, Newton, IA 50208 Phone: 641-792-1273 Fax: 641-791-4852 |
Steven James Ashing, EMTP Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 2300 Law Center Dr, Newton, IA 50208 Phone: 641-792-5912 |
News Archive
University of Notre Dame researchers, as part of a collaborative effort, have identified a protein that potentially could be a target for drugs that would help people recover faster from jet lag and better adjust their circadian rhythms during rotational shift work.
Every tumor is different, every patient is different. So how do we know which treatment will work best for the patient and eradicate the cancer? In order to offer a personalised treatment that best suits the case being treated, a team of scientists led by the University of Geneva (UNIGE), Switzerland, had already developed a spheroidal reproduction of tumors that integrates the tumor cells, but also their microenvironment.
EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing acute-care hospital products, today announced that the US Patent and Trademark Office has issued two new patents covering methods of treatment and methods of preparation for the Company's Ready-to-Use (RTU) CardeneĀ® I.V. (nicardipine hydrochloride) Premixed Injection.
Researchers have developed the technology for a catheter-based device that would provide forward-looking, real-time, three-dimensional imaging from inside the heart, coronary arteries and peripheral blood vessels. With its volumetric imaging, the new device could better guide surgeons working in the heart, and potentially allow more of patients' clogged arteries to be cleared without major surgery.
› Verified 5 days ago